Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Return on Assets: 2011-2025

Historic Return on Assets for Northwest Biotherapeutics (NWBO) over the last 15 years, with Sep 2025 value amounting to -2.44%.

  • Northwest Biotherapeutics' Return on Assets fell 2.00% to -2.44% in Q3 2025 from the same period last year, while for Sep 2025 it was -2.44%, marking a year-over-year decrease of 2.00%. This contributed to the annual value of -2.72% for FY2024, which is 67.00% down from last year.
  • As of Q3 2025, Northwest Biotherapeutics' Return on Assets stood at -2.44%, which was up 5.08% from -2.57% recorded in Q2 2025.
  • Northwest Biotherapeutics' Return on Assets' 5-year high stood at -1.44% during Q1 2022, with a 5-year trough of -3.67% in Q2 2021.
  • In the last 3 years, Northwest Biotherapeutics' Return on Assets had a median value of -2.40% in 2024 and averaged -2.38%.
  • In the last 5 years, Northwest Biotherapeutics' Return on Assets slumped by 103bps in 2021 and then spiked by 186bps in 2022.
  • Northwest Biotherapeutics' Return on Assets (Quarterly) stood at -1.69% in 2021, then crashed by 66bps to -2.35% in 2022, then increased by 30bps to -2.05% in 2023, then crashed by 60bps to -2.65% in 2024, then fell by 2bps to -2.44% in 2025.
  • Its last three reported values are -2.44% in Q3 2025, -2.57% for Q2 2025, and -2.80% during Q1 2025.